Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Therapeutics

Therapy Area Medical Writing, Statistics and Regulatory Documentation

Pubrica supports pharmaceutical and device teams, sponsors and investigators with medical writing, statistical analysis, regulatory documentation, health economics and publications, organised by therapy area. A single programme can include the protocol, statistical analysis plan, clinical study report, dossier modules and the publications that follow. We assign writers by indication, so each project is handled by someone familiar with the study designs, reporting guidelines, regulatory pathway and journals in that area. The areas below are those where we hold standing expertise. If your indication is not listed, contact us: we will tell you whether we have a matched expert, and decline if we do not.

Across one programmeone named lead

Study design, endpoints, reproducible analysis outputs, ICH-structured documents and related publications.

Every programme
  • Assigned by indication
  • One named lead throughout
  • Reporting guideline identified
  • Mutual NDA on request
  • You are the author or sponsor

Service Scope

One project lead from protocol to publication

Each therapy area has its own endpoints and reporting guidelines. In every programme, a lead who knows the guideline your design requires checks whether each endpoint supports the claims made from it.

Protocol

Design and endpoints

Study design, endpoints and the statistical analysis plan developed together.

Analysis

Reproducible outputs

Reproducible code and outputs a reviewer can trace back to the dataset.

Clinical study report

ICH E3

Clinical study reports structured to ICH E3, including narratives and appendices.

Dossier

Modules 2.4 and 2.5

CTD clinical overviews and summaries, and the HTA submissions based on them.

Publications

Timed to data readouts

Congress abstracts and primary manuscripts, under ICMJE authorship.

Throughout

One named lead

A designated project lead keeps data interpretation and messaging consistent across regulatory documents and manuscripts.

Therapy areas

Sixteen therapy areas we support

Each card lists the typical study types and documents in that area. If your indication is not listed, contact us.

Therapy areaOncology & haematologySupport for oncology and haematology sponsors and investigators: RECIST and iRECIST reporting, survival analysis, study reports and submissions to high-impact oncology journals. Therapy areaCardiovascularSupport for cardiovascular trial teams: CONSORT 2025 trial reporting, cardiovascular outcome trial documentation and registry analysis for submissions and publications. Therapy areaEndocrinology & diabetesSupport for endocrinology and diabetes researchers: metabolic cohort analysis, glycaemic endpoint reporting and dataset-driven association studies for publication. Therapy areaNeurologySupport for neurology sponsors and investigators: reporting of imaging endpoints and disability scales, and design of longitudinal cohort studies. Therapy areaPsychiatry & mental healthSupport for psychiatry and mental health researchers: rating-scale validation, blinding assessment and reporting of behavioural outcomes in trials and publications. Therapy areaImmunology & inflammationSupport for immunology sponsors: biologic comparability and immunogenicity reporting, and mechanism-of-action writing for regulatory and scientific documents. Therapy areaInfectious disease & vaccinesSupport for infectious disease and vaccine teams: transmission modelling, efficacy reporting and public-health evidence for submissions and publications. Therapy areaRespiratorySupport for respiratory sponsors: spirometry endpoint reporting, inhaled device studies and exacerbation-rate analysis for study reports and manuscripts. Therapy areaRare diseaseSupport for rare disease sponsors: small-population trial designs, natural-history studies and orphan designation dossiers. Therapy areaDermatologySupport for dermatology researchers: lesion scoring, photographic evidence standards and reporting of topical formulation studies. Therapy areaOphthalmologySupport for ophthalmology sponsors: visual-acuity endpoint reporting, imaging data integrity and device evaluation reports. Therapy areaWomen’s healthSupport for women’s health researchers: obstetric and gynaecological trials, reproductive outcome studies and registry analysis. Therapy areaPaediatricsSupport for paediatric programmes: age-appropriate endpoints, assent documentation and paediatric investigation plans. Therapy areaMusculoskeletalSupport for musculoskeletal researchers: patient-reported outcomes, orthopaedic device evidence and surgical case series for publication. Therapy areaNephrology & urologySupport for nephrology and urology teams: eGFR endpoint reporting, dialysis cohort analysis and renal outcome reporting. Therapy areaGastroenterology & hepatologySupport for gastroenterology and hepatology researchers: endoscopic scoring, fibrosis endpoint reporting and microbiome study design.

Clinical areas

Clinical areas we cover

Each clinical area has its own study designs and reporting guidelines, and we assign writers on that basis.

Who We Serve

Teams we support by therapy area

Sponsors, device teams and payer-facing teams organise evidence by therapy area. The free scoping read is written for the team that requests it.

Teams we work with

Regulatory affairsDossier modules and health-authority responses in your indication
Medical affairsPublication plans and congress content timed to data readouts
Clinical developmentProtocols and study reports that follow the applicable reporting guideline
Market accessValue dossiers built for the agency that assesses your indication
BiostatisticsAnalysis plans and estimands appropriate to the endpoint
Principal investigatorsPrimary manuscripts and the responses that follow review

Core Workstreams

Four workstreams, adapted to each therapy area

Endpoints, guideline extensions and assessing agencies vary by therapy area. The core services stay the same.

Four workstreams, in every therapy area

Regulatory writingClinical overviews, study reports and dossier modules written to ICH structure for that therapy area
Publication planningCongress abstracts, primary manuscripts and secondary analyses timed to the data readouts
Health economicsCost-effectiveness and budget-impact evidence built for the payers who assess that indication
Real-world evidenceRegistry, claims and EHR studies designed around the endpoints used in that therapy area

Area-Specific Requirements

Four requirements that vary by therapy area

This is why we assign writers by sub-specialty rather than by general medicine.

What moves between therapy areas

The reporting guidelineCONSORT for a trial, STROBE for a cohort, STARD for diagnostic accuracy, TRIPOD+AI for a prediction model. The study design determines the guideline, not the field
Key analysis issuesSurvival extrapolation in oncology, unit of randomisation in emergency care, prevalence and predictive values in diagnostics
The regulatory pathICH and the CTD for a medicine; MDR or IVDR and a notified body for a device, each with different documents and reviewers
The journalsEach journal’s scope, statistical review policy and house style requirements

Our compliance and guideline standards

Guidelines applied at the current edition

We apply the guideline and extension your design requires and record the edition used. Writing to the current edition reduces the risk of findings linked to superseded guidance.

Standards we apply

CONSORT 2025Trials, with the pilot, cluster and non-inferiority extensions
STROBEObservational and cohort studies
STARDDiagnostic accuracy studies
TRIPOD+AIPrediction models, including imaging AI
ARRIVE 2.0Animal and preclinical studies
PRISMA 2020 and GRADEEvidence synthesis and certainty of evidence
CHEERS 2022Health economic evaluation
COREQ and ENTREQQualitative and mixed-methods research
ICH E3, E6, E9 and M4Regulatory documents and the CTD
MDR and IVDRDevice and diagnostic evaluation

How it works

Five steps, starting with a free scoping read

We review your programme before providing a quote.

One

Scoping read

Free, within two business days: what the programme needs, who would lead it and the expected cost.

Two

Named lead

A lead matched to the indication is assigned before work starts and coordinates the programme throughout.

Three

Outline approval

Every section and its source, approved before drafting.

Four

Drafting and review

Independent review, QC and reference verification, each signed off separately.

Five

Handover

The deliverable with its working material, revised within the agreed scope.

After

Follow-up questions

Reviewer and health-authority questions are answered by the writer of the document.

Sample work

Sample deliverables

Published where the client agreed, redacted where they asked.

Benefits

Benefits of indication-matched teams

What clients receive on every programme.

What you get

Correct reporting guidelineThe applicable guideline extension is confirmed in the scoping read, before drafting
Consistent documentsA designated project lead keeps the clinical overview and manuscripts consistent
Known review pointsWriters experienced in contested analyses, such as survival extrapolation, identify where reviewers are likely to question the work
Unlimited revisions within the agreed scopeWithin the agreed scope, without a per-round charge
Clear advice on fitIf no one on our panel is a suitable match, we tell you
You are the authorNamed throughout; we do not offer ghost authorship

Therapy area or subject area?

Choosing the right list

This page organises our expertise by therapy area, as industry teams do. The subject areas page organises it by academic discipline.

What you came for, and where it is

You organise work around an indicationTherapy areas — this page, which cuts across disciplines
You work in an academic disciplineSubject areas — 69 disciplines, from cardiology to nanotechnology
You are in a regulated sectorIndustries — twelve sectors and the regulation each answers to
You want to learn the skillAcademy — free guidance on writing, reading and interpreting

Therapeutics FAQs

Questions about therapy areas and matching.

If your question is not answered here, ask an expert. No quote is required.

A subject area is the academic discipline — cardiology, microbiology, genomics. A therapy area is how industry organises evidence around an indication, and it cuts across disciplines: a vaccine programme needs immunology, epidemiology, statistics and regulatory writing at once. Most academic authors want the subject list; most pharma and device teams want this one.

Contact us. The list covers areas where we hold standing expertise, not every area we work in. For an unusual indication we will tell you whether we have a subject matter expert, and decline if we do not. If the closest match is an expert in an adjacent field, we say so.

Yes. A designated project lead coordinates the protocol, statistical analysis plan, clinical study report and publications in your therapy area to keep data interpretation and messaging consistent.

Yes, including the extensions. CONSORT has extensions for pilot, cluster and non-inferiority trials; oncology adds RECIST; prediction models add TRIPOD+AI. We confirm the correct extension in the scoping read.

Specific enough that the expert can question the analysis. For a trial that usually means the sub-specialty; for a broad review, the discipline is often enough. We will tell you which we have before you commit.

Yes. Animal studies are reported to ARRIVE 2.0, which journals increasingly check. We pay particular attention to sample size justification and randomisation reporting, where animal manuscripts most often fall short.

Device and diagnostic work follows its own regulation: clinical evaluation under MDR and performance evaluation under IVDR, reviewed by a notified body rather than a journal. It is covered on our device and IVD pages and handled by a separate team from trial manuscript editing.

Yes, contact us. Our panel covers many areas not named on this page. If we do not have a suitable subject match, we will tell you rather than assign someone from an adjacent field as a specialist.

Discuss your therapy area project requirements

Tell us your indication and deadline. The free scoping read takes two business days and gives you a written view of what the programme needs and who would lead it, including whether our closest expert is in your sub-specialty or an adjacent one.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.